Liam Twomey (Wexford, Fine Gael)
Link to this: Individually | In context

Question 98: To ask the Tánaiste and Minister for Health and Children if tablets and injections (details supplied) will be restored on the GMS drug scheme to ensure that medical card patients with cancer are not disadvantaged in the range of medication they can have to counteract the side effects of their treatment. [6411/05]

Mary Harney (Dublin Mid West, Progressive Democrats)
Link to this: Individually | In context

There is a common list of reimbursable medicines for the general medical services and drug payment schemes. This list ensures equity between the schemes in relation to the range of medicines paid for by the State. The list is reviewed and amended monthly, as new products become available and deletions are notified.

For an item to be included on the common list, it must comply with a published list of criteria. These include authorisation status where appropriate, price and, in certain cases, the intended use of the product. In addition, the product should ordinarily be supplied to the public only by medical prescription and should not be advertised or promoted to the public.

A medical cardholder who experiences financial difficulty in obtaining items not on the common list should approach the health board for assistance.

There is an agreement in place between my Department, the Irish Pharmaceutical Healthcare Association and the Association of Pharmaceutical Manufacturers of Ireland on the supply terms, conditions and prices of medicines supplied to the health services, that is, the general medical services, other community drug schemes, Health Service Executive and hospitals. One of the conditions of the agreement is that the price to wholesaler of each item of medicine covered by the agreement may not be increased for the term of the agreement. The manufacturers of the product referred to by the Deputy applied to my Department for a price increase in December 2003 which was refused. The product was subsequently removed from the list of reimbursable drugs and medicines at the manufacturer's request. However, because of the indications for which this product is prescribed, my Department is reviewing the matter.